• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates

tetano

Editor, Senior Moderator
Virology. 2015 Apr 16;482:234-243. doi: 10.1016/j.virol.2015.03.051. [Epub ahead of print]
[h=1]Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates.[/h] Ye J[SUP]1[/SUP], Wen F[SUP]1[/SUP], Xu Y[SUP]1[/SUP], Zhao N[SUP]1[/SUP], Long L[SUP]1[/SUP], Sun H[SUP]1[/SUP], Yang J[SUP]1[/SUP], Cooley J[SUP]2[/SUP], Todd Pharr G[SUP]1[/SUP], Webby R[SUP]3[/SUP], Wan XF[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Vaccination is the primary strategy for the prevention and control of influenza outbreaks. However, the manufacture of influenza vaccine requires a high-yield seed strain, and the conventional methods for generating such strains are time consuming. In this study, we developed a novel method to rapidly generate high-yield candidate vaccine strains by integrating error-prone PCR, site-directed mutagenesis strategies, and reverse genetics. We used this method to generate seed strains for the influenza A(H1N1)pdm09 virus and produced six high-yield candidate strains. We used a mouse model to assess the efficacy of two of the six candidate strains as a vaccine seed virus: both strains provided complete protection in mice against lethal challenge, thus validating our method. Results confirmed that the efficacy of these candidate vaccine seed strains was not affected by the yield-optimization procedure.
Copyright ? 2015 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Error-prone PCR; High-yield strain; Influenza A virus; Vaccine; Vaccine production

PMID: 25899178 [PubMed - as supplied by publisher]
 
Back
Top Bottom